Buscar

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Leer más About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Leer más About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Renown Health is pleased to announce the appointment of Anna Loomis, MBA, as its new Chief Financial Officer (CFO), effective 1ro de julio de 2024. Ms. Loomis will oversee all aspects of financial management for Renown Health including budgeting, financial planning, revenue cycle management, supply chain and strategic investments for Nevada’s #1 ranked health care organization.    Before joining Renown, Ms. Loomis served as Senior Vice President (SVP) and CFO with Portland-based Legacy Health, and prior to that as SVP and Chief Financial Officer for Washington-based MultiCare for more than 15 years.  With over 20 years in finance leadership and strategy, Ms. Loomis has led several transformative efforts to strengthen the organizations and build partnerships.    “We are thrilled to welcome Anna Loomis to our executive team,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “Anna is an approachable, innovative, and resilient leader. Her proven track record of financial stewardship and her deep understanding of the complexities of the healthcare landscape make her an ideal fit for the team. The essential role that Renown Health plays as the only local, not-for-profit, charitable healthcare network in Washoe County will be furthered by her commitment. We are confident that with her guidance and expertise, we will continue to strengthen our financial position while advancing our mission to deliver the highest quality care and service to patients.”    Anna earned her master’s and bachelor’s degree in business administration from Pacific Lutheran University (Tacoma, WA); completed a finance fellowship with The Academy GE Fellows Program and serves on the Board of Directors for PacificSource health plans.   As of Aug. 2023, Fitch Ratings affirmed the 'A+' long-term rating on the series 2020A, 2020B, 2015A and 2016A bonds issued on behalf of Renown Health, NV by Public Finance Authority (Renown Regional Medical Center Project). In addition, Fitch has affirmed Renown's IDR at 'A+'. Renown's 'A+' revenue bond ratings and the Outlook revision to Stable are primarily driven by the system's midrange operating risk profile assessment, which has rebounded significantly over the past 12-months. Both the rating and Stable Outlook incorporate Renown's position as the service area's single largest provider of high-end acute care services and maintenance of the leading market position, with approximately two-thirds of all patients in northern Nevada seeking care at Renown. The rating is further informed by Renown's solid balance sheet metrics, which remain intact at or near historical levels. Given significant consumer demand for Renown providers and services, a master facility planning process and strategic planning process has been undertaken to ensure that Renown has adequate bed and procedure capacity, spaces to accommodate new technology and services to meet the needs of a growing patient base and community. As the region’s only Level 2 Trauma Center for both adults and children, Renown serves over 1 million people and 100,000 square miles across Nevada, Lake Tahoe, and northeast California. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center has been named #1 in the State of Nevada for the last three years.   Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Visite renown.org para obtener más información.

Leer más About Renown Health Appoints Anna Loomis MBA As Chief Financial Officer

Amy McGaha, MD, MPH, FAAFP has joined the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health as department chair of Family and Community Medicine. Dr. McGaha comes to Nevada from Omaha, Nebraska where she served as the Roland L. Kleeberger, MD professor and chair for the Creighton University School of Medicine, Department of Family Medicine.  Dr. McGaha previously served as the assistant director of medical education for the American Academy of Family Physicians (AAFP), the professional membership association for family physicians, working to develop family medicine workforce and medical education. She has also served on the Board of Trustees for the Society of Teachers of Family Medicine and on the board for CHI Health, the clinical partner of Creighton University School of Medicine. Prior to those appointments, Dr. McGaha provided inpatient and outpatient care for Freeman Health Systems in Missouri. Dr. McGaha completed her education at the University of Missouri School of Medicine in Columbia and completed her residency in family medicine in Tallahassee, Florida. Dr. McGaha also completed a Master of Public Health (MPH) degree at the Milken Institute School of Public Health at George Washington University. She is a fellow of the AAFP. Dr. McGaha will serve as the joint academic and administrative leader defining clinical operations to expand care, enhancing teaching and training programs vital to ambulatory and acute care medicine in northern Nevada and fostering clinical and translational research and diversity missions. “I am delighted to welcome Dr. McGaha,” said Paul J. Hauptman, MD, dean of UNR Med and chief academic officer for Renown Health. “As our new chair for Family and Community Medicine, she brings to us a wealth of experience, dedication and innovation that will continue to elevate the quality of care we provide to patients and the excellence in education we offer to students. Dr. McGaha has a strong background in academic medicine, distinction in clinical care, medical education, and research, and is universally respected as a compassionate physician leader. Dr. McGaha will do much to advance the mission of our Family Medicine Residency program and expand related Graduate Medical Education (GME) opportunities, shaping the future of family medicine in northern Nevada and beyond.” “Dr. McGaha will help bolster our commitment to providing exceptional primary care services to our community. With her guidance, we will advance patient-centered care, train the next generation of health care professionals and foster a culture of innovation within our academic health system,” said Brian Erling, MD, MBA, president and CEO of Renown Health. “This is an exciting time for Dr. McGaha to help craft our vision to offer more efficient and affordable care, elevate the patient experience and advance health equity across northern Nevada. We are fortunate to have her joining our team and our community.” Dr. McGaha will spearhead initiatives to enhance clinical outcomes, promote preventative health measures and foster collaboration among health care providers to optimize patient care delivery. In addition, Dr. McGaha will oversee the Family Medicine Residency, a full-scope, fully accredited program at UNR Med. Graduates practice in various settings, both rural and urban, solo family medicine and in large provider groups, traditional outpatient family medicine and as hospitalists or urgent care physicians. Dr. McGaha’s research has explored maternal health equity. She designed a Medical-Financial Collaborative Care Practice Model to address social determinants of health in patients with Type 2 diabetes. She has also presented nationally on diverse topics, such as “Advancing Inclusion and Belonging in Health Science Education” and “Innovating Interprofessional Collaboration in a Primary Care Setting.” An author of 25 academic papers, she has a long history of community service to schools, hospice organizations and neighborhood health clinics. Dr. McGaha has won many awards for her work in medical education, including the AIHC Interprofessional Practice Award, induction into the Gold Humanism Honor Society at Creighton University, the AAFP Foundation Pfizer Immunization Grant Award, the Physicians Recognition Award from the American Medical Association, and the Ellen Beck Faculty Award for Medical Staff Outstanding Commitment. The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents, and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national, and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health.

Leer más About Amy McGaha, MD, MPH, FAAFP Appointed Chair of Family and Community Medicine

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program. Las Vegas, Nev. (2 de mayo de 2019) – El Healthy Nevada Project, un estudio de salud poblacional basado en la comunidad primero en su clase que combina datos genéticos, clínicos, ambientales y sociales, está ampliando la inscripción a Las Vegas. The Project aspires not only to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile but ultimately, to develop and expand the Project for communities across the United States to drive positive health outcomes nationwide.   Se agregarán 25,000 voluntarios del estudio en el sur de Nevada El Healthy Nevada Project anuncia extensión a nivel estatal: abre 25,000 vacantes para pruebas en Las Vegas. Ahora que el sur de Nevada abre sus puertas al estudio, el Healthy Nevada Project ofrecerá pruebas genéticas sin costo mediante una muestra de saliva simple a 25,000 voluntarios del estudio. Study volunteers will take Helix’s clinical-grade DNA saliva test and will receive their ancestry and traits, at no cost, through the My Healthy Nevada Traits app. Participants will then be given a chance to answer a follow-up health survey from Renown Institute for Health Innovation (Renown IHI), and upon survey completion, will be entered to win an iPhone. In addition, study participants can agree to be notified about genetic test results that could impact their health, and which could be used to improve their medical care. This return of clinical results, plus genetic counseling and other genetic services as appropriate, will be provided by Genome Medical, the leading network of clinical genetics specialists.   Evolución y expansión continua del Healthy Nevada Project Con más de 35,000 participantes del estudio inscritos en apenas más de dos años, el Healthy Nevada Project se ha convertido en el estudio genético de más rápida inscripción del país. The Project was created by Renown IHI – a collaboration between Reno, Nev.-based not-for-profit health network, Renown Health, and the world leader in environmental data, Desert Research Institute (DRI). Leveraging Renown’s forward-thinking approach to community health care and DRI’s data analytics and environmental expertise, Renown IHI has grown its capabilities to lead a larger, more complex research study of significance that will analyze and model public health risks in Nevada and serve as a national model for future population health studies working to improve overall health through clinical care integration. En el lanzamiento piloto del proyecto el 2016 de septiembre, se inscribieron más de 10,000 miembros de la comunidad para realizarse pruebas de ADN en solo 48 horas. En marzo de 2018, en la fase dos, se les ofreció a los residentes del norte de Nevada secuenciación genómica completa mediante una simple prueba de saliva de Helix. En octubre de 2018, el proyecto anunció la devolución de los resultados clínicos a los participantes del estudio. Allí se notificaba el riesgo que tenían de padecer afecciones de Nivel 1 de los CDC, que incluyen hipercolesterolemia familiar, BRCA1 y BRCA2 positivo, y síndrome de Lynch, un precursor del cáncer de colon. These conditions affect more than one percent of the population and are inherited so they impact family members as well. Ahora, el proyecto anunció su próxima fase: la extensión de la inscripción a 25,000 personas del sur de Nevada.   Serving as a National Model This expansion to Las Vegas truly makes this the “Healthy Nevada Project” with a statewide impact making Nevada the only state in the U.S. to offer such a program. “Nevada was ripe to advance population health goals because, sadly, our state ranks near the bottom in health outcomes. The Healthy Nevada Project is working to change that,” said Anthony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health and president of Renown IHI. “Nuestros investigadores están trabajando en una serie de programas clínicos y estudios científicos para determinar por qué en el condado de Washoe, el condado en el que se encuentra Renown Health, las tasas de mortalidad etarias para enfermedad cardíaca, cáncer y enfermedad crónica de las vías respiratorias inferiores de Nevada son un 33 por ciento más altas que la tasa nacional. Imagine if we can gather more data like this on a national scale and use it to change the future of health and health care? That is what the Healthy USA Project is looking to do in the years to come.” “The Healthy Nevada Project is committed to providing study participants clinically actionable data that will help improve their health,” said Joseph Grzymski, Ph.D., associate research professor at DRI, principal investigator of the Healthy Nevada Project and chief scientific officer for Renown Health. “We are providing this information at the individual level so study volunteers can make lifesaving changes to reduce their risk. We’re also doing it on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country.”   Expanding to Become the Healthy USA Project The accelerated speed of the Project is made possible thanks to the ever-decreasing cost of sequencing. Hoy en día, Helix puede secuenciar un exoma completo, lo que permite informar sobre la mayoría de los conocimientos genómicos prácticos, por una fracción de lo que habría costado hace solo 10 años. Additionally, advances in digital health mean Helix and Project researchers can capture unprecedented amounts of health data digitally, making significant contributions to advancing precision health. The partnership has managed to remove the traditional barriers of population health studies, including the difficulty in recruiting participants, establishing quality high through put lab systems, and scaling interpretation and return of results. This development will be key as other health systems around the country join the Project. “We are thrilled to see the constant, fast-paced evolution of this Project with Renown IHI,” said Justin Kao, CoFounder of Helix. “In less than a year, we have sequenced the DNA of thousands of study participants and are now preparing to offer this incredible study in other states. Combining environmental, clinical, social and genetic data allows us to discover risk factors within communities and help people take action to live longer, healthier lives. That’s what makes the next step of the Healthy USA Project so exciting for all of us. “Los detalles completos sobre la evolución del estudio y de la inscripción en el sur de Nevada se darán a conocer en un evento de prensa en Las Vegas el martes 7 de mayo a las 3 p.m. Renown Institute for Health Innovation es una colaboración entre Renown Health, una red de atención médica integrada de administración y propiedad local y sin fines de lucro que brinda servicios a Nevada, Lake Tahoe y el noreste de California, y el Desert Research Institute, líder mundial reconocido en la investigación de los efectos del cambio ambiental natural e inducido por el humano y en la promoción de tecnologías para la evaluación de un planeta cambiante. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Obtenga más información en https://healthynv.org/.  Helix es una empresa de genómica con una misión simple pero potente: to empower every person to improve their life through DNA. Our affordable, turnkey population health solution enables institutions to quickly scale projects that engage communities and accelerate research and discovery, ultimately allowing every person to benefit from the power of genomics. We've also created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners, providing powerful tools to increase engagement and speed the pace of population-scale genomics. Helix is headquartered in the San Francisco Bay Area, has an office in Denver, Colorado and operates a CLIA-certified and CAP-accredited next-generation sequencing lab in San Diego powered by Illumina (NASDAQ: ILMN) NGS technology. Helix fue creada en 2015. Obtenga más información en www.helix.com. Helix, el logotipo de Helix y Exome+ son marcas comerciales de Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.   Additional Media Contacts: Tracy Bower                                                                                                                                                                          DRI                                                                                                                                                                                      702-862-5404                                                                                                                                                      media@dri.edu Eric Schubert                                                                                                                                                                        Seismic for Helix                                                                                                                                                                    415-939-4366                                                                                                                                                    press@helix.com

Leer más About Estudio de salud poblacional se extiende a todo el estado y abre la inscripción

Renown Health Board of Directors Chair, Jim DeVolld, Receives Nevada Hospital Association’s Commitment to Community Award for Trustee Excellence Award. Renown Health Board of Directors Chair, Jim DeVolld has been awarded the prestigious 2019 Commitment to Community Award for Trustee Excellence from the Nevada Hospital Association (NHA). Each year at the association’s annual meeting, the Nevada Hospital Association publicly acknowledges one trustee who exemplifies exceptional leadership and the characteristics to which all hospital and health system Board leaders should aspire, including: Professional excellence Outstanding achievements Innovative accomplishments Extraordinary compassion in caring for the community Success in overcoming barriers, and Exemplary contributions to effectively advocate on behalf of hospitals, patients, and the healthcare system. “Jim DeVolld’s personal connection and passion for improving the community’s overall health are what drive his commitment to the Renown Health Board,” NHA’s President & CEO, Bill Welch said. “Under Jim’s leadership, Renown Health is nationally recognized for top levels of quality and safety, most notably through advances made in clinical care, the adoption of health information technology and the development of team-based and patient-centered medical homes.” DeVolld was nominated by President & CEO of Renown Health, Anthony D. Slonim, MD, D.Ph. and his senior leadership team at Renown Health. Gracias al apoyo de Jim y de la Junta, el sistema de atención médica integrado incluye ahora cuatro campus hospitalarios; 120 centros de atención primaria, de urgencia y especializada; afiliaciones con Stanford Medicine, la Facultad de Medicina de la University of Nevada, Reno, la Facultad de Medicina de St. George’s University (SGU) en Grenada; y un plan de salud, Hometown Health, que presta servicios a más de 180,000 miembros. Los más de 7,000 empleados y 800 proveedores de Renown Health sirven como el centro de atención de derivación regional para un radio de más de 100,000 millas cuadradas, que abarca desde Sacramento hasta Salt Lake City. Se presentó un ensayo en el que se describía con profunda admiración el liderazgo de DeVolld al frente de la Junta Directiva de Renown Health integrada por 43 miembros y en el que se relataba una larga lista de logros de la organización. One nominee stated, “Jim sets a stellar example as a Board Chair who tirelessly advocates for improvement, inclusion, responsibility, preparation, taking the ‘high road,’ and the importance of collaborative, positive relationships. Jim’s commitment has extended beyond traditional healthcare to include economic health and community health and well-being. “Jim DeVolld, nevadense de toda la vida, creció en Yerington antes de trasladarse a Reno hace 31 años. Jim DeVolld’s32-year-old daughter was born at Renown Regional Medical Center and his family receives care at Renown Health. Jim DeVolld’s personal connection and passion for improving the community’s overall health are what drive his commitment to the Renown Health Board. Para garantizar la atención de primera categoría que nuestra comunidad espera y merece, él se ha centrado primero en el cuidado de los 7,000 empleados de Renown que proporcionan una atención excepcional cada día. Luego de desempeñarse durante ocho años en diversas funciones en la Junta Directiva de Renown Health, Jim DeVolld, director ejecutivo de Banca Comercial de First Independent Bank, fue elegido presidente de la Junta Directiva de Renown Health por un periodo de dos años, con vigencia a partir del 1ro de enero de 2019. Renown’s four governing boards serve a key role in achieving Renown’s mission of making a genuine difference in the health and well-being of the people and communities in Northern Nevada. Board members help guide the health system with the charitable mission of “making a genuine difference in the health and well-being,” based on the principles of caring, integrity, collaboration and excellence. Jim DeVolld has spent decades working in the Northern Nevada banking industry. He also serves as chairman of the Nevada Tax Commission and is a board member of the Boys and Girls Club of Truckee Meadows.     About the NHA The Nevada Hospital Association is a not-for-profit, statewide trade association representing Nevada’s acute care hospitals along with psychiatric, rehabilitation and other specialty hospitals as well as health related agencies and organizations throughout the state. Allied with the American Hospital Association, the NHA is an independent organization headquartered in Reno, Nev. About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. Visite renown.org para obtener más información.

Leer más About Renown Board of Directors Chair, Jim DeVolld, Receives NHA Award

El Dr. Tony Slonim, director ejecutivo de Renown Health, es elegido para ocupar el cargo más alto de la American Hospital Association.  El presidente y director ejecutivo de Renown Health, el Dr. Anthony Slonim M.D., DrPH, FACHE, ha sido elegido para desempeñarse como miembro de la Junta Directiva de la American Hospital Association (AHA) durante un período de tres años a partir del 1 de enero de 2022. The Board of Trustees is the highest policymaking body of the AHA and has ultimate authority for the governance and management of the organization. La American Hospital Association (AHA) es la organización nacional que representa a más de 40,000 miembros individuales y sirve a más de 5,000 hospitales y redes de atención médica, así como a sus pacientes y comunidades. As a representative and advocate for those serving in the health care field, Dr. Slonim's role as a Trustee will be to ensure that members' perspectives and needs are heard and addressed in national health policy development, legislative and regulatory debates, and judicial matters. Dr. Slonim joins an elite list of CEOs from the nation’s most respected health care organizations in AHA Board service, including Yale New Haven Health (CT), Dartmouth Hitchcock Health (NH), Providence Health (WA), Henry Ford Health (MI), UMass Memorial Health (MA), Vanderbilt University Medical Center (TN), and Advocate Aurora Health (WI). La American Hospital Association se fundó en 1898, el mismo año que Marie Curie comenzó a estudiar el uranio como tratamiento contra el cáncer. Dr. Slonim is among the first health care leaders from Nevada elected to serve on the AHA Board of Trustees. In an announcement to the national media, the AHA wrote, “Anthony Slonim, MD, DrPH, leads Renown's charitable mission of making a genuine difference in the community's health and well-being for one of the nation's most innovative and progressive health systems.” Steve Sisolak, gobernador del estado de Nevada, en apoyo a la nominación del Dr. Slonim escribió: “Tanto el Dr. Slonim como yo compartimos un interés común por mejorar la salud de más de 3 millones de residentes de nuestro estado. I urge you to appoint him to this position, as his national leadership would benefit the American Hospital Association, our state and our nation.” Brian Sandoval, President of the University of Nevada wrote in his nomination, “Dr. Slonim has always answered the call, and worked with me to improve health through proactive community-based prevention, to create an exceptional healthcare system for those with acute and chronic diseases, and to care for all people in our community.” Bill Welch, President and CEO of the Nevada Hospital Association, wrote in support, “I consider Dr. Anthony Slonim  to be one of the most extraordinary leaders in health care today.” Dr. Slonim is recognized nationally as a thought and opinion leader who does not accept the status quo. He is a quadruple board-certified physician by training and holds a Doctorate in Public Health and Health Policy with Fellowships in the American College of Healthcare Executives (ACHE), American Association of Physician Leaders (AAPL), and the College of Critical Care Medicine. Dr. Slonim’s holds a university appointment at the University of Nevada, Reno School of Medicine, is a highly sought after speaker on healthcare trends and leadership development, holds a Six Sigma Black Belt and is a 2-time TEDx speaker. El Dr. Slonim es autor de más de 120 publicaciones, 15 libros de texto y cuenta con millones de dólares en fondos para investigación. Modern Healthcare ha nombrado al Dr. Slonim como uno de los 50 líderes más influyentes en el ámbito de la atención médica. Su nombre ha figurado en la lista de “Líderes médicos que debería conocer” de Becker’s Hospital Review desde 2014. Antes de unirse a Renown Health en 2014, Slonim participó en los equipos de liderazgo sénior de Barnabas Health en Nueva Jersey, Carilion Clinic en Virginia y Children’s National Medical Center en Washington, D.C. Slonim, que también era enfermero certificado, obtuvo su título médico en New York Medical College, sirvió durante cuatro años en el U.S. Public Health Service Commissioned Corps como comandante, y obtuvo su maestría y doctorado en salud pública y políticas de salud en el Center for Health Policy Studies de la George Washington University.     Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown has a long tradition and commitment to improving the care and the health of our community. Visite renown.org para obtener más información.

Leer más About Una prestigiosa distinción destaca a nivel nacional la atención médica en Nevada

El presidente y director general de Renown Health, el Dr. Tony Slonim, ha sido reconocido como uno de los 50 ejecutivos clínicos más influyentes de Modern Healthcare de Estados Unidos El presidente y director ejecutivo de Renown Health, Anthony Slonim, M.D., DrPH, FACHE, ha sido seleccionado como uno de los ejecutivos clínicos más influyentes de los Estados Unidos por su innovación y liderazgo en la atención médica a nivel nacional. El Dr. Slonim se incluye en una lista de élite de 50 galardonados respetados identificados como “Los ejecutivos clínicos más influyentes” de Modern Healthcare. The list features leaders from top-rated institutions across the country including an impressive list of that includes Dr. Anthony Fauci, director, National Institute of Allergy & Infectious Diseases, Dr. Rochelle Walensky, director, Centers for Disease Control and Prevention, and colleagues from Weill Cornell Medicine, Yale School of Medicine, UCLA Health and more. Fawn Lopez, publisher and vice president of Modern Healthcare, the industry's leading source of healthcare business and policy news, research and information, noted, “Under Slonim’s leadership, Renown a couple of years ago launched the Healthy Nevada Project® with the goal of doing comprehensive population health work. El proyecto ha secuenciado los datos genéticos de 60,000 participantes en el estudio y se ha extendido por todo el estado. The system is also building a new clinically integrated network after joining forces with the University of Nevada School of Medicine. En 2018, el gobernador nombró a Slonim como uno de los dos responsables de hospitales de la Comisión de Protección del Paciente del estado, que asesora a los legisladores en cuestiones de acceso e igualdad. During the pandemic, Renown was an early leader in adopting home monitoring systems, offering free ICU beds to those in need, and expanding disease monitoring. Slonim wrote passionately about the loss of his father to COVID and used that experience as the backdrop to advocate for more family and staff support structures.” “Under Dr. Slonim’s leadership, Renown Health is an extraordinary force for good in our community,” said James DeVolld, chair of the Renown Health Board and Managing Director, Commercial Banking at First Independent Bank. “He leads by example to serve our patients, employees and community, helping pave the way for other leaders and physicians to thrive at Renown. We are honored to serve our community alongside Tony as we work together to make a genuine difference for those we serve.” “We never would have anticipated the challenges we encountered through the pandemic. The highest priority of all CEOs - whether you are the leader of a state or a health system - is to ensure safety and the public’s health. Saber que contaba con un equipo sólido para tomar medidas de mitigación, preparación, respuesta, comunicación y recuperación en torno al brote de COVID 19 y para proporcionar acceso a la atención a las personas que más nos necesitaban, me dio la confianza necesaria y el Dr. Slonim fue una parte fundamental de ese equipo”, dijo Steve Sisolak, gobernador del estado de Nevada. “Little did we know we would also face an economic crisis, political turmoil and significant social unrest. While at times these challenges seemed daunting, they also accelerated our ability to learn and grow together, to prove we could manage through times of great ambiguity, to move at unprecedented speeds, and have ultimately prepared us to change our world for the better. On reflection, it turned out that we could not have asked for better preparation for our future. Thank you, Dr. Slonim.” “Tony is just getting started! Renown Health and the University of Nevada, Reno School of Medicine (UNR Med) have announced our affiliation and the creation of the first integrated health system in northern Nevada, said Brian Sandoval, President, University of Nevada, Reno. “Dr. Slonim has always answered the call, and worked with me to improve health through proactive community-based prevention, to create an exceptional healthcare system for those with acute and chronic diseases, and to care for all people in our community. We are so fortunate to have him in Nevada.” During Dr. Slonim’s career at major healthcare organizations and academic institutions, he has developed a national profile as an academic leader and tenured professor, holding appointments as clinical professor in the departments of internal medicine and pediatrics at the University of Nevada, Reno School of Medicine. Dr. Slonim is also an expert in patient safety, accountable care, health care quality and innovative care delivery models focused on improving health within the community. Desde que se unió a Renown como director ejecutivo y presidente en julio de 2014, el Dr. Slonim ha reorientado por completo la red de atención médica sin fines de lucro y de administración local más grande del norte de Nevada. Con una pasión personal por la salud de la población, el Dr. Slonim creó el Institute for Healthcare Innovation, donde lanzó el primer estudio de salud poblacional basado en la comunidad del país, que actualmente cuenta con más de 60,000 participantes y está entregando los resultados clínicos sobre las tres primeras afecciones genéticas identificadas. The Healthy Nevada Project® is a collaboration with global leader in environmental data, Desert Research Institute, and personal genomics company, Helix. The Healthy Nevada Project combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state, and the nation. El programa de premios y reconocimientos “Los 50 ejecutivos clínicos más influyentes” distingue a las personas de la industria de la atención médica que, a juicio de sus colegas y de los editores sénior de Modern Healthcare, están allanando el camino hacia una mejor salud gracias a su responsabilidad ejecutiva, sus cualidades de liderazgo, su servicio a la comunidad y sus logros dentro y fuera de su organización. La clasificación final de la lista de los 50 más influyentes se basa en los votos de los lectores, así como en los aportes de los editores sénior de Modern Healthcare. El Dr. Slonim figuraba en la lista inicial de 150 nominados publicada en marzo de 2021. For more information about the program, please contact Jodi Sniegocki.    Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.

Leer más About Una prestigiosa distinción destaca a nivel nacional la atención médica en Nevada

Chuck Podesta, national IT leader to use technology to improve the health and well-being of Nevadans. Renown Health is pleased to announce Charles (Chuck) Podesta has been named Chief Information Officer. Podesta es un ejecutivo experimentado con más de 30 años de experiencia al frente de algunos de los mejores equipos de TI de la industria de atención médica del país. He has literally worked from coast to coast and is excited to bring his talents to Nevada. “We are pleased to bring an experienced and talented leader like Chuck Podesta to lead our information and technology areas at Renown,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “As Chief Information Officer, he will have the opportunity to foster a culture of innovation and excellence in information technology which serves hundreds of thousands of people across the state and the nation. Chuck will use the power of technology to bring a new level of convenience to patients and providers and will use his talents and team to improve the health and well-being of Nevadans.” Chuck most recently served as Interim Chief Information Officer for UCONN Health’s John Dempsey Medical Center, School of Medicine and Clinical Research IT. Prior to that, Chuck served as CIO for UCI Health/UC Irvine School of Medicine and the University of California Health System. He also served as CIO for University of Vermont Health Network/Fletcher Allen Health; Steward Health/Caritas Christi Healthcare; Berkshire Health; Baystate Health and UMASS Medical Center, all in the New England area. Podesta está especializado en crear planes tecnológicos estratégicos, los dota de recursos y los implementa; maximizar el poder del registro médico electrónico EPIC; racionalizar la gobernanza y las prioridades; alinear las necesidades informáticas médicas y de TI en todas las entidades afiliadas, lo que incluye el entorno de las facultades de medicina, las organizaciones de atención responsable (Accountable Care Organization, ACO), las redes clínicas integradas (Clinically Integrated Networks, CIN) y los consultorios médicos; establecer asociaciones para implementar las mejores herramientas digitales impulsadas por el cliente; liderar la participación en intercambios de información de salud (health information exchange, HIE) en todo el estado, y entrenar y asesora a los equipos de TI.   “Chuck’s experience and strengths in a variety of diverse and complex environments make him the perfect leader for us at this important time in our history,” explains Josiah (Sy) Johnson, Chief of Staff for Renown. Chuck will assure we are leading with innovative and contemporary approaches and integrating technology and expertise in our ongoing pursuit of excellence in improving health and healthcare in Nevada. “I am honored and excited to join the Renown Health family and the northern Nevada community,” says Chuck Podesta, Chief Information Officer. “I am impressed with the innovation and transformation at Renown; which has earned it a reputation as one of the nation’s leading health systems. I look forward to joining Renown Health at this exciting time in its history. I am excited to bring my skills and experience to create a positive experience when people use our technology. I am looking forward to leading the organization on this important journey.” Podesta is a graduate of the Massachusetts College of Liberal Arts and an active member of CHIME, HIMSS and the Society for Information Management (SIM). Podesta comenzará en Renown el 12 de julio.   About Renown Health Renown Health is the region’s largest, local not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,200 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information, visit renown.org.

Leer más About Renown Health le da la bienvenida al nuevo director de Tecnología de la Información

Dr. Graf will support clinical providers in delivering the most effective, highest-quality patient care at lowest cost. Renown Health se complace en anunciar que el Dr. Thomas Graf se une a la organización como director clínico y de calidad en septiembre de 20. In this role, Dr. Graf will support clinicians in delivering the most effective, highest-quality patient care at the lowest cost. Dr. Graf will also assist Renown in expanding innovative care models like Hospital at Home and remote patient monitoring technology to deliver patient-centered health care that both convenient and affordable. “At Renown, delivering the highest quality care is our #1 priority. Embracing our vision to improve the health of our community, we are pleased to welcome an experienced leader like Dr. Graf to our organization and to Nevada,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. “As the Chief Clinical and Quality Officer, Tom will fuel Renown’s transformation to a value-based care organization, help advance technologies to enhance the patient experience, and collaborate with providers in our medical group, acute care hospitals, and through our clinically integrated network, accountable care organization and affiliation with UNR Med to create a healthier Nevada. Dr. Graf embodies our core values of caring, integrity, collaboration and excellence, and respect for all. We are thrilled to bring him to the Silver State, and to continue to offer health care that is affordable, accessible and of the highest quality.” Graf is a highly accomplished physician executive with leadership experience from leading health care and insurance organizations as well as a national consulting firm. El Dr. Graf, médico de medicina de familia, investigador y académico, se ha centrado en impulsar mejoras de calidad para reducir el costo total de la atención. Ha desarrollado y hecho publicaciones sobre modelos de atención que han logrado resultados mensurablemente mejores en cuanto a calidad, costo y experiencia en una variedad de centros. Ha ejercido en un sistema de prestación de servicios integrado, por más de una década en Geisinger (PA), así como en redes clínicamente integradas y en organizaciones de atención responsable. También ha trabajado con varios centros médicos académicos en el área de consultoría con The Chartis Group. El Dr. Graf es respetado por su estilo de liderazgo efectivo y adaptable, y por su capacidad de crear consenso mediante perspectivas compartidas. El Dr. Graf agrega: “Mi objetivo es generar mayor valor para el paciente al brindarle atención de la más alta calidad clínica. Renown has a national reputation for delivering excellent care using approaches that are creative, innovative and maximize technology, and I look forward to engaging physicians and administrators in an agenda that supports this vision.” El Dr. Graf llega Renown desde Ascension en St. Louis, Misuri, donde se desempeñó como vicepresidente sénior, director de Salud de la Población y director de Atención Basada en el Valor. Tiene una amplia experiencia en salud de la población, ya que ha participado en la reingeniería clínica y la evolución del modelo de pago desde 2005 con los Centers for Medicare & Medicaid Services en el Proyecto de Demostración de Consultorios de Grupos Médicos, así como en los programas Proven Care® y ProvenHealth Navigator® de Geisinger. “Choosing a physician and hospital for their care is one of the most important decisions people will ever make. I am excited to begin my work with Renown to help patients enhance their health and well-being,” said Dr. Graf. “I am grateful for the opportunity to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care. I am excited to join this journey of transformation to value- based care, and to serve patients, clinicians and the community.” Dr. Graf will report directly to Dr. Tony Slonim, president and CEO, Renown Health. Dr. Graf earned his Doctor of Medicine from University of Michigan, Ann Arbor, and completed his Family Practice Residency at Henry Ford Health System in Detroit.     En los rankings de mejores hospitales de U.S. News y World Report, Renown Regional Medical Center ocupa el primer puesto en el estado de Nevada para 2021. Ningún otro hospital en Nevada obtuvo el reconocimiento de U.S. News. Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000 personas. It comprises three acute care hospitals, the region's only children's hospital, a rehabilitation hospital, the area's most comprehensive medical group and urgent care network, and the region's largest and only locally owned not-for-profit insurance company, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad. Visite renown.org para obtener más información.

Leer más About Renown da la bienvenida al nuevo director clínico y de calidad, Thomas Graf, MD

Dr. Morgan embraces a patient-centered approach to delivering a comprehensive cardiac and vascular program in Nevada. Renown Health is excited to announce that Dr. Jayson Morgan has been promoted to serve as Director of the Cardiovascular Services. El Dr. Morgan, quien anteriormente se desempeñaba como jefe de la División de Cardiología, comenzó en su nuevo puesto en septiembre de 6. Dr. Morgan plays a key role in supporting clinical and administrative leaders to embrace a patient-centered approach in delivering the most effective, highest-quality care within the Institute for Heart and Vascular Health and across Renown Health. Dr. Morgan will expand care, enhance clinical outcomes and transform cardiovascular health care through adopting technological advances which promote patient-centered health care that is both convenient and affordable. “At Renown, delivering the highest quality care is our #1 priority. Embracing our vision to improve the health of Nevadans, we are pleased to promote an extraordinary physician like Dr. Morgan to lead and further develop cardiovascular services - and elevate and grow this important Destination Health program to serve the growing needs of our community,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. “Unfortunately, Heart Disease continues to be the #1 cause of death in Washoe County, the state and the nation. Dr. Morgan and his team focus on saving lives and reducing the number of people needing heart and vascular interventions. He embodies our core values of caring, integrity, collaboration and excellence, and respect for all, and we are pleased to have Dr. Morgan at the helm of our cardiovascular program.” Dr. Jayson Morgan is a highly accomplished physician leader. He served as both an Internal Medicine Hospitalist and an Internal Medicine resident at UCSF Health in San Francisco, where he specialized in the care of advanced heart failure, pulmonary hypertension, and heart transplant patients. Completó su beca en cardiología en el Cedars-Sinai Medical Center en Beverly Hills, California en 2017 e inmediatamente después se unió a Renown. En 2019, se desempeñó como director del laboratorio de ecocardiografía en Renown. En 2020, fue ascendido a jefe de la División de Cardiología. “The experts at Renown’s Institute for Heart and Vascular Health provide an integrated, multi-disciplinary, patient-centered approach to the prevention, diagnosis and treatment of heart and vascular disease. I am proud to have Dr. Jayson Morgan leading a team of experts who respond to and treat heart and vascular problems that extend from mild to the most critical of emergencies. Our specialized physicians (cardiologists, interventional radiologists, heart and vascular surgeons) work collaboratively with our clinical team to determine the best treatment plan for each patient,” says Rahul Mediwala, MD, Medical Director, Health Services. “High blood pressure, heart disease, and stroke affect one in three Nevada residents. Estas enfermedades son prevenibles y muchos eventos agudos pueden evitarse si se llevan estilos de vida saludables, que incluyen no consumir tabaco, limitar el sodio y adoptar una dieta a base de vegetales, realizar al menos 30 minutos de actividad física por día, limitar o eliminar el consumo de alcohol y seguir los regímenes de medicamentos recetados. Together, we can make a genuine difference in improving the health of our families, friends and neighbors,” says Jayson Morgan, MD, FACC, Director, Cardiovascular Services. “We are pleased to offer a medically supervised, Pritikin-certified, intensive cardiac rehabilitation (ICR) program for those with heart disease. Our expert team creates tailored plans, providing the support heart patients need to make lasting lifestyle changes.” El Dr. Morgan continúa: “Renown ahora cuenta con 3 cirujanos cardíacos, 17 cardiólogos y 16 proveedores de práctica avanzada que brindan una excelente atención cardiovascular. Nuestras capacidades técnicas se han expandido con un Programa de Tratamiento de Enfermedad Cardíaca Estructural que incluye reemplazo de válvula aórtica transcatéter (trans catheter aortic valve replacement, TAVR), reparaciones de la válvula mitral transcatéter (Mitraclip), cierres de agujero oval persistente y cierres de defecto del tabique auricular; con más de 100 procedimientos cardíacos estructurales realizados cada año. Our Cardiothoracic surgeons are the highest volume in the region and consistently exceed national performance standards for operative care. Renown Regional Medical Center was the first hospital in the region to implant the CardioMEMS pulmonary artery pressure monitoring system for advanced heart failure patients, dramatically reducing hospitalizations in these patients. Three interventional cardiologists have joined our team which has expanded our capacity to handle interventions for complex coronary artery disease. Los tres electrofisiólogos de Renown han realizado más de 1000 procedimientos este año, lo cual ha disminuido drásticamente la carga sintomática de la fibrilación auricular en nuestra comunidad. In addition, with the UNR Medical School affiliation, we look forward to even greater contributions to cardiovascular research.” Dr. Morgan graduated from Stanford University School of Medicine and graduated from Yale University with his undergraduate education in Chemical Engineering. “I am excited to continue to help patients enhance their health and well-being,” said Dr. Morgan. “I am grateful for the opportunity to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care. I am excited to advance our journey of transformation to value-based care, and to serve patients, clinicians and the community.” To make an appointment with a provider at Renown’s Institute for Heart and Vascular Health, request that your primary care provider make a referral. For more information on Renown’s Institute for Heart and Vascular Health, visit renown.org/Health-Services/Heart-Care. Renown Institute for Health and Vascular Health is the recipient of a number of national awards for outstanding clinical care and service, including: En los rankings de Mejores Hospitales de U.S. News and World Report de 2021, Renown Regional Medical Center ocupa el primer puesto en el estado de Nevada para 2021. Ningún otro hospital en Nevada obtuvo el reconocimiento de U.S. News. Renown Regional Medical Center is High Performing, its highest rating possible, for Heart Failure and Chronic Obstructive Pulmonary Disease. Renown Regional recibió el premio America's 100 Best Hospitals for Critical Care Award™ (2021) del American College of Surgeons por la obtención de resultados clínicos superiores en el tratamiento de embolia pulmonar, insuficiencia del sistema respiratorio, sepsis y emergencias diabéticas. El Regional también ganó el Pulmonary Care Excellence Award (2021) por la obtención de resultados superiores. Designated Level II Trauma Center. For the 30th year, Renown Regional Medical Center is northern Nevada's only designated level II trauma center. Renown Regional awarded The Get with the Guidelines – Heart Failure Gold Plus Quality Achievement award for continually ensuring heart failure patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, as well as AHA’s Mission: Lifeline Gold Receiving honor for the treatment of patients who suffer severe heart attacks. American College of Cardiology’s NCDR Chest Pain ̶ MI Registry Platinum Performance Achievement Award. El Renown Regional Medical Center es uno de los únicos 225 hospitales de todo el país en recibir el premio. The award recognizes Renown’s success in implementing a higher standard of care for heart attack patients and signifies that Renown has reached an aggressive goal of treating these patients to standard levels of care as outlined by the American College of Cardiology/American Heart Association clinical guidelines and recommendations.     Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad. Visite renown.org para obtener más información.

Leer más About Renown da la bienvenida al director de Servicios Cardiovasculares, Jayson Morgan, MD, FACC

Juntos, realizarán pruebas a más de 30,000 participantes del estudio elegibles antes de 2023 para determinar el riesgo de cirrosis y enfermedades relacionadas con el hígado. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. La enfermedad de hígado graso no alcohólico (EHGNA), que incluye la EHNA, es frecuente en Nevada y está subdiagnosticada, y probablemente afecte a más de 500,000 adultos en nuestro estado. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. Hay más de 12,000 personas en la lista de espera para trasplante de hígado en los EE. UU. y esta cifra continúa aumentando debido al incremento en la prevalencia de la EHGNA. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. Es increíblemente gratificante poder informar hallazgos clínicos para ayudar a nuestros 50,000 participantes voluntarios del estudio y asistir a los proveedores de atención médica a ayudar a sus pacientes”. La provisión de la prueba de ELF se basa en una colaboración estratégica anunciada previamente entre el Renown IHI y Gilead en julio de 2019. Esta sociedad en curso tiene como objetivo recopilar y analizar datos de salud genéticos y electrónicos anónimos de 60,000 participantes del estudio elegibles con el fin de mejorar la comprensión de la EHGNA y la EHNA y para potencialmente orientar el desarrollo de opciones de tratamiento para estas enfermedades. Acerca de la EHGNA y la EHNA La EHGNA es una acumulación de grasa en el hígado en personas que no tienen antecedentes de abuso de alcohol. Es normal que el hígado contenga algo de grasa, pero si más del 5 por ciento del contenido hepático es grasa, se considera hígado graso (esteatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. Aproximadamente, un tercio de las personas con EHNA desarrollan cirrosis o daño hepático irreversible (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. Para obtener más información o para inscribirse, comuníquese a la casilla de correo RenownIHI@renown.org o al teléfono (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene más de 60,000 participantes. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. En el año fiscal 2020, que finalizó el 30 de septiembre de 2020, Siemens Healthineers, que tiene aproximadamente 54,000 empleados en todo el mundo, generó ingresos por €14.5 mil millones y un EBIT ajustado de €2.2 mil millones. Encontrará más información disponible en www.siemens-healthineers.com.Media Contacto de Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Leer más About Renown Institute Expands Partnership to Offer ELF Testing